Search alternatives:
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
381
-
382
GSH, but not GSSG, specifically decreases ABCB10 ATP binding activity.
Published 2015“…<p>A representative autoradiography image and the quantification shown in the bar graph demonstrate that GSH decreased [α-<sup>32</sup>P] 8-azido-ATP signal in ABCB10 from SMPs in a dose dependent manner, whereas GSSG did not. …”
-
383
-
384
-
385
-
386
-
387
<i>USP28</i> protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in A549 cells.
Published 2013“…<p>(A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human <i>HIF-1α</i> and <i>HIF-2α</i> (<i>HIF-1α</i> RNAi and <i>HIF-2α</i> RNAi mixture) for 48 hr, and then were treated with 1.0 mM NiSO<sub>4</sub> or cultured in 1% O<sub>2</sub> (Hy) for another 24 hr. …”
-
388
-
389
-
390
Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice.
Published 2013“…White line indicates the presence of tumor. <b>Panel b:</b> A boxplot of tumor burden in MDA-MB-231 tumor-bearing mice treated with either 13C4 (10 mg/kg) or 1D11(10 mg/kg) for 4 weeks, starting 1 day after tumor cell injection (N = at least 7) showing decrease in tumor burden. …”
-
391
-
392
-
393
-
394
-
395
-
396
-
397
LPS decreases cardiac expression of miR-29c for 3–7 days.
Published 2014“…(n = 3), or 7 days after LPS (10 mg/kg i.p.) (n = 3). There was a significant decrease in miR-29c with LPS (P = 0.02, one way ANOVA). …”
-
398
-
399
<i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
Published 2019“…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”
-
400